Office: FXB, 405B
Senior Research Scientists
Office: FXB 405D
Abdoulaye Dieng Sarr
Dr. Jolayemi is a public health physician and Project Director of the PEPFAR funded AIDS Prevention Initiative in Nigeria (APIN). She is also an HSPH alumni. APIN provides comprehensive support for HIV/AIDS prevention, care and treatment programs as well as program management and capacity building in hospitals and at the National Institute of Medical Research in Nigeria. Currently she oversees all APIN Ltd/Gte programmatic areas, and more specifically, is responsible for coordinating in-country Strategic Information, Monitoring & Evaluation, and Human Subject functions. Dr. Jolayemi manages training and coordinates the human subject/ethics and IRB related activities within APIN’s scope of work.
Kegakilwe Catherine Koofhethile
Catherine’s work centers on prevention to reduce the incidence of HIV/AIDS and characterization of viruses circulating in the HIV-1C epidemic.
Visiting Associate Professor
Dr. Blackard received his undergraduate degree in Biology from the University of Arkansas in Fayetteville, AR (1994) followed by a PhD in Biological Sciences in Public Health at Harvard University in Boston, MA (2000). His dissertation work focused on genetic diversity of the human immunodeficiency virus (HIV) during perinatal transmission and included research in Japan, Tanzania, and Honduras. His post-doctoral fellowship (2002-05) was conducted at the Massachusetts General Hospital in Boston, MA where he investigated the interactions of flaviviruses with HIV.
He directs a basic and translational research laboratory that focuses on human and mechanistic studies to understand the interactions between various viral pathogens. In the Kanki Laboratory he is involved in the mentoring of PhD students, working on research presentations and seminars, and the presentation of course-based lectures.
Bobby Brooke Herrera
Bobby Brooke is a co-founder and chief scientific officer at E25Bio (The Engine by MIT). E25Bio’s lab focuses on infectious disease immunology and diagnostic/software development. He will work with the Kanki lab to study the impact of Zika virus infection on pregnant women in Africa. He holds a Ph.D. in Biological Sciences in Public Health and a master’s degree in philosophy from Harvard. Prior to co-founding the company, he was a postdoctoral research fellow at Harvard Medical School.
Office: FXB, 405D
Seema focuses her efforts on providing programmatic support for the AIDS Prevention Initiative in Nigeria (APIN)/Harvard PEPFAR Program in Nigeria, works closely with colleagues at Nigerian medical institutions on building research capacity of faculty members, and works with data collected during the PEPFAR program to conduct evaluations on antiretroviral therapy (ART) and PMTCT outcomes, HIV/HBV co-infection, HIV/HCV co-infection, HIV drug resistance, and HIV adherence.
Office: FXB, RM 405
Office: AIDS Prevention Nigeria
Phone: +23422412626 x2359
As Chief Executive Officer of the APIN Program in Nigeria, Prosper focuses his efforts at providing broad oversight at the strategic level to the entire program. This includes the PEPFAR, Global fund and other NIH supported grants, and has provided enabling environment for continued research capacity building with impressive outputs through publications. His research interests are around implementation science and health systems, particularly at secondary and primary levels of care and research outcomes are being constantly applied to improve program performance.
Office: FXB, 405A
Charlotte manages clinical data for HIV research projects and evaluations, particularly those associated with the Harvard/APIN PEPFAR-Nigeria Antiretroviral Treatment Programs for HIV/AIDS. Data activities include data validation, extraction, formatting, reporting, analysis, manuscript preparation, and providing technical assistance to PEPFAR partners. She also acts as a liaison with investigators and ethical review boards to ensure regulatory compliance of research studies for the Kanki lab and affiliates.
Office: FXB, RM 405A
Office: FXB, RM 405
Office: FXB, 405D
Don studies HIV diversity using molecular methods in a number of African cohorts. He leads workshops on sequencing, molecular cloning, real time PCR, as well as immunologic techniques. His areas of interest are HIV-1 subtypes, HIV-2, technology and automation in the laboratory, and laboratory development in resource poor settings.